Avivagen Inc. ( VIVXF) - Key Metrics
VIVXF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q3 | $0 | -$0.01 | $0 | $0 |
| 2023Q2 | $0 | -$0.02 | $0 | $0 |
| 2023Q1 | $0 | -$0.01 | $0 | $0 |
| 2022Q4 | $0.01 | -$0.02 | -$0.01 | -$0.01 |
| 2022Q3 | $0 | -$0.03 | -$0.02 | -$0.02 |
VIVXF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q3 | 0% | -2.75 |
| 2023Q2 | 0% | -4.38 |
| 2023Q1 | 0% | -19.22 |
| 2022Q4 | 0% | -20.15 |
| 2022Q3 | 0% | -14.48 |
VIVXF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2023Q3 | 0.70% | 0% |
| 2023Q2 | 0.26% | 0% |
| 2023Q1 | -0.15% | 0% |
| 2022Q4 | -0.70% | 0% |
| 2022Q3 | -1.03% | 0% |
VIVXF
Price: $0
52 week price:
Earnings Per Share: -0.04 USD
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 12509